Price (delayed)
$7.45
Market cap
$173.55M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.39
Enterprise value
$177.65M
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated
There are no recent dividends present for DERM.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.